budesonide (Rhinocort, Pulmicort, Turbuhaler, Flexhaler, Entocort EC, Uceris, Cortiment, Eohilia)
Jump to navigation
Jump to search
Introduction
Tradenames: Rhinocort, Pulmicort, Turbuhaler, Flexhaler, Pulmicort Respules (solution for nebulizer), Entocort EC, Eohilia
Indications
- atopy, allergic rhinintis
- prophylaxis for asthma in adults & children > 6 years
- COPD[8]
- acute flares of Crohn's disease
- Entocort EC targets the ileum & ascending colon
- advantage over other steroids is reduced systemic effect
- ulcerative colitis
- Uceris targets the entire colon
- budesonide oral suspension (Eohilia) first oral treatment for eosinophilic esophagitis[10]
Contraindications
Caution:
- inhaler
- low systemic absorption
- will NOT provide glucocorticoid coverage for adrenal insufficiency (i.e. systemic steroid withdrawal)
Dosage
- nasal spray: 2 sprays BID or 4 sprays QD.
- inhaler:
- nebulizer BID, 0.25 & 0.5 mg/mL amps
- oral: 9 mg PO QAM
- no intravenous formulation
Capsules: 3 mg
Pharmacokinetics
- nasal spray: effects measureable within 5 hours & persist > 12 hours[4]
- metabolized by cyt P450 3A4 on 1st pass through liver
- very little reaches systemic circulation
elimination via liver
Adverse effects
- common (> 10%)
- less common (1-10%)
- insomnia, psychic changes, asthenia, pain, dyspepsia, nausea, anorexia, increased appetite, dry mouth, dry throat, alteration in voice, oral candidiasis, increased cough, ecchymosis, pharyngitis
- uncommon (< 1&)
- other
- irritation of nasal mucosa
- rarely nasal ulceration
- oral candidiasis (thrush)
Drug interactions
- agents that inhibit cyt P450 3A4 may inhibit metabolism of budesonide (clarithromycin & others)[5]
- agents which induce cyt P450 3A4 may enhance metabolism of budesonide
- avoid grapefruit juice
- drug interaction(s) of methotrexate with biological response modifier
- drug interaction(s) of glucocorticoids with warfarin
- drug interaction(s) of NSAIDs with glucocorticoid
Laboratory
Notes
- Uceris costs ~$1200/month vs ~$4 for prednisone
More general terms
Additional terms
Component of
- albuterol/budesonide (Airspura)
- budesonide/formoterol/glycopyrrolate (Breztri Aerosphere)
- budesonide/formoterol (Symbicort)
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 743
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ 4.0 4.1 Journal Watch 20(9):70, 2000 Day et al J Allergy Clin Immunol 105:489, 2000
- ↑ 5.0 5.1 5.2 Prescriber's Letter 14(6): 2007 Pulmicort Flexhaler (Budesonide Inhalation Powder) Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=2306209&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ Prescriber's Letter 17(7): 2010 Clarithromycin Interaction with Salmeterol and Inhaled Corticosteroids Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=260701&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ Prescriber's Letter 20(3): 2013 Treatments for Ulcerative Colitis Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=290303&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 8.0 8.1 Deprecated Reference
- ↑ 9.0 9.1 Hoy SM. Budesonide MMX: a review of its use in patients with mild to moderate ulcerative colitis. Drugs. 2015 May;75(8):879-86. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25920500
- ↑ 10.0 10.1 Brooks M FDA OKs First Oral Agent for Eosinophilic Esophagitis. Medscape. Feb 12, 2024 https://www.medscape.com/viewarticle/fda-oks-first-oral-agent-eosinophilic-esophagitis-2024a100031d
Database
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5281004
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3033890
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2462
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=657195
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=470826
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=63006
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=40000